Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial - An educational program to reduce the stigma of schizophrenia among community pharmacists

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043189

Enrollment

120

Registered

2021-01-30

Start date

2019-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General population

Interventions

A 60-minute communicating with patients with schizophrenia and a 60-minute lecture on schizophrenia A 60-minute lecture on schizophrenia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A community pharmacist with over a year of work experience as a pharmacist

Exclusion criteria

Exclusion criteria: A community pharmacist with less than a year of work experience as a pharmacist A pharmacist who works outside the insurance pharmacy

Design outcomes

Primary

Measure	Time frame
The amount of change in the degree of stigma for schizophrenia patients before and after intervention by using the Stigma Scale towards Schizophrenia for Community Pharmacists	—

Countries

Japan

Contacts

Public ContactHiroyuki Kamei

Meijo University Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy

hkamei@meijo-u.ac.jp052-839-2643

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026